Valuation : Optiscan Imaging Limited

Market Cap 157M 113M 97.25M 91.5M 83.5M 156M 10.72B 1.08B 419M 5.48B 425M 415M 17.44B P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 144M 104M 89.18M 83.9M 76.56M 143M 9.83B 994M 385M 5.03B 389M 381M 15.99B EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.32%
Yield 2025 *
-
Yield 2026 -
1 week-6.25%
Current month-3.23%
1 month-18.92%
3 months+11.11%
6 months+68.54%
Current year+50.00%
1 week 0.14
Extreme 0.14
0.16
1 month 0.14
Extreme 0.135
0.2
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.08
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.26
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 13/12/2021
Director of Finance/CFO - 31/03/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 10/02/2021
Chairman - 19/04/2021
Director/Board Member - 06/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
22/05/26 Sell

Director

-3,000,000 0.2873%
15/01/26 Free

Director

230,502 0.0221%
15/01/26 Free

Chairman

419,094 0.0401%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.25%+76.47%+94.81% 113M
-0.22%+1.23%-32.41%+0.84% 13.03B
-2.38%-2.96%+8.35%+13.86% 4.28B
+1.73%+6.38%-42.15%-50.12% 1.33B
0.00%-4.19%-41.84%-40.45% 1.13B
-0.18%-1.85%+17.65%+80.06% 1.08B
-1.34%-3.81% - - 1.03B
+0.19%-4.51%-37.79% - 1.03B
+1.47%-0.64%+34.10%+115.15% 529M
+3.38%+11.05%+84.97% - 318M
Average +0.26%+0.89%+7.48%+30.59% 2.39B
Weighted average by Cap. -0.43%+1.39%-19.96%+5.39%

Financials

2025 2026
Net sales 3.72M 2.69M 2.31M 2.18M 1.99M 3.71M 255M 25.78M 9.97M 130M 10.1M 9.88M 415M 3.61M 2.61M 2.24M 2.11M 1.93M 3.59M 247M 25.01M 9.68M 126M 9.8M 9.59M 402M
Net income -6.31M -4.56M -3.92M -3.69M -3.36M -6.28M -432M -43.69M -16.9M -221M -17.12M -16.74M -703M -6.99M -5.05M -4.34M -4.08M -3.72M -6.95M -478M -48.35M -18.71M -244M -18.95M -18.53M -778M
Net Debt -3.07M -2.22M -1.91M -1.79M -1.64M -3.05M -210M -21.25M -8.22M -107M -8.33M -8.15M -342M -13.01M -9.39M -8.08M -7.6M -6.93M -12.94M -891M -90.03M -34.83M -455M -35.27M -34.5M -1.45B
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
09/09/26 A$0.1500 0.00% 5,854
08/09/26 A$0.1500 0.00% 376,399
07/09/26 A$0.1500 0.00% 33,955
04/09/26 A$0.1500 +3.45% 23,793
03/09/26 A$0.1450 -9.38% 49,008
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!